CardioTech AdvanSource Biomaterials

<p>Symbol of Advansource is ASB &#160;(on AMEX)

&#160;

&#160;

Feb 12, 2008 12:22 PM

&#160;

I listen to the conference call today at 11:30AM Pacific ... very disappointing in re Cardiopass.

They have NOT recruited even ten patients for their trial (they were supposed to be done by now).

They added a second site to recruit (? second hospital) in Europe where the trial is being done.

They did not say how many patients they already have.

They expect to be done with the trial by the fall (another 9 months)... (they need 3 months of

follow-up for each patient). &#160;They claim they are very picky abt which patients to include (want patients

who can take all the meds (presumably the anticoagulants).

The analysts were clearly disappointed.

&#160;

Second, they were talking about selling off Cardiopass after it is approved so they focus on their core business -

biomaterials.

&#160;

They have also gotten approval for a second (smaller) size - a 4 mm &#160;graft (? outside or inside diam).</p>